Compare · LGMK vs ZBH
LGMK vs ZBH
Side-by-side comparison of LogicMark Inc. (LGMK) and Zimmer Biomet Holdings Inc. (ZBH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both LGMK and ZBH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ZBH carries a market cap of $19.12B.
- Over the past year, LGMK is up 0.0% and ZBH is down 6.8% - LGMK leads by 6.8 points.
- LGMK has been more active in the news (9 items in the past 4 weeks vs 7 for ZBH).
- ZBH has more recent analyst coverage (25 ratings vs 0 for LGMK).
- Company
- LogicMark Inc.
- Zimmer Biomet Holdings Inc.
- Price
- $0.01-6.67%
- $100.18-0.67%
- Market cap
- -
- $19.12B
- 1M return
- +0.00%
- +8.84%
- 1Y return
- +0.00%
- -6.84%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 9
- 7
- Recent ratings
- 0
- 25
LogicMark Inc.
LogicMark, Inc. offers personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company, through its subsidiary, LogicMark LLC, manufactures and distributes non-monitored and monitored personal emergency response systems sold through healthcare durable medical equipment and monitored security dealers/distributors, and the United States Department of Veterans Affairs. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.
Zimmer Biomet Holdings Inc.
Zimmer Biomet Holdings, Inc., together with its subsidiaries, designs, manufactures, and markets musculoskeletal healthcare products and solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company provides orthopaedic reconstructive products, such as knee and hip replacement products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers dental products that include dental reconstructive implants, and dental prosthetic and regenerative products, as well as surgical, bone cement, and office-based technology products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Latest LGMK
- Amendment: SEC Form SC 13E3/A filed by LogicMark Inc.
- SEC Form DEFM14A filed by LogicMark Inc.
- SEC Form 10-Q filed by LogicMark Inc.
- SEC Form NT 10-Q filed by LogicMark Inc.
- SEC Form SC 13E3 filed by LogicMark Inc.
- SEC Form PREM14A filed by LogicMark Inc.
- SEC Form D filed by LogicMark Inc.
- SEC Form 425 filed by LogicMark Inc.
- LogicMark Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
- LogicMark Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Latest ZBH
- Amendment: SEC Form SCHEDULE 13G/A filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- SEC Form 4 filed by President, APAC Desai Chintan
- SEC Form 10-Q filed by Zimmer Biomet Holdings Inc.
- Zimmer Biomet Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Zimmer Biomet Announces Second Quarter 2026 Financial Results
- Grp Pres-Global Business Thornal Kevin R converted options into 9,957 shares and covered exercise/tax liability with 4,266 shares (SEC Form 4) (tax liability)
- UBS initiated coverage on Zimmer Biomet with a new price target
- SEC Form 3 filed by new insider Desai Chintan
- Zimmer Biomet Names Chintan Desai President of Asia Pacific Region